In your state
Arkansas

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: Arkansas

$4.8B

Total output supported by biopharmaceutical sector

$257.1M

Tax Revenue Generated

16,179

Total Jobs

2,838

Direct Jobs

Clinical Trials in Your State: Arkansas

382

TOTAL CLINICAL TRIALS

$109 million

INVESTED IN CLINICAL TRIALS

6,386

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$265 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: Arkansas


State programs and initiatives to promote biopharmaceutical industry development

    ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT

    BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE

    ECONOMIC INNOVATION INCENTIVES

    STEM EDUCATION & WORKFORCE DEVELOPMENT

    TARGETED STRATEGIES

    VENTURE FINANCING

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.